Regular ArticlesCaveolin-1 (P132L), a Common Breast Cancer Mutation, Confers Mammary Cell Invasiveness and Defines a Novel Stem Cell/Metastasis-Associated Gene Signature
Cited by (0)
Supported by the National Institutes of Health (National Cancer Institute grants R01-CA-80250, R01-CA-098779, and R01-CA-120876 to M.P.L.; R01-CA-70896, R01-CA-75503, R01-CA-86072, and R01-CA-107382 to R.G.P.; and a cancer center core grant P30-CA-56036 to the Kimmel Cancer Center), the American Association for Cancer Research (to M.P.L.), the Department of Defense (Breast Cancer Research Program synergistic idea award to M.P.L.), the Susan G. Komen Breast Cancer Foundation (investigator-initiated grant to M.P.L., a postdoctoral fellowship to I.M., and a career catalyst award to P.G.F.), the Elsa U. Pardee Foundation (to F.S.), the W.W. Smith Charitable Trust (to F.S. and P.G.F.), the American Cancer Society (research scholar grant to F.S.), the Breast Cancer Alliance (young investigator award to F.S.), the American Heart Association (to F.C), “La Ligue Contre le Cancer comité du Haut-Rhin” (to F.A., M.-C.R., and C.T.), and the Pennsylvania Department of Health (to M.P.L.) (the Department specifically disclaims responsibility for any analyses, interpretations or conclusions).
Supplemental material for this article can be found on http://ajp.amjpathol.org.
A guest editor acted as editor-in-chief for this manuscript. No person at Thomas Jefferson University or Albert Einstein College of Medicine was involved in the peer review process or final disposition for this article.